How Strong Is The Human Clinical Evidence That Apigenin Improves Sleep?

Oct 30, 2025

Leave a message

The human clinical evidence supporting apigenin's role in improving sleep is promising but still limited. Apigenin, a natural flavonoid found in chamomile and other plants, has shown potential sleep-enhancing properties in preliminary studies. While research on apigenin powder specifically is scarce, studies using chamomile extracts containing apigenin have demonstrated modest improvements in sleep quality and duration. However, more robust clinical trials are needed to fully establish the efficacy of apigenin for sleep disorders. The current evidence suggests that apigenin may help promote relaxation and reduce anxiety, potentially contributing to better sleep, but larger-scale human studies are required to draw definitive conclusions.

 

 

Clinical Studies: Chamomile Extract, Natural Source Containing Apigenin

 

Randomized controlled trials on chamomile tea and sleep

Several randomized controlled trials have investigated the effects of chamomile tea, a natural source of apigenin, on sleep quality. One notable study published in the journal BMC Complementary and Alternative Medicine examined the impact of chamomile tea consumption on sleep quality in elderly individuals. The researchers found that participants who consumed chamomile tea daily for four weeks reported significant improvements in sleep quality compared to the control group. Another study, conducted by researchers at the University of Pennsylvania, explored the effects of chamomile extract on individuals with chronic insomnia. The results showed that chamomile extract led to modest improvements in sleep onset and efficiency, although the differences were not statistically significant. These findings suggest that while chamomile may have some sleep-promoting properties, its effects may be subtle and vary among individuals.

 

Apigenin content and bioavailability in chamomile extracts

The apigenin content in chamomile extracts can vary depending on factors such as the plant's growing conditions, extraction methods, and processing techniques. Studies have shown that chamomile tea typically contains between 0.8% to 1.2% apigenin by weight. However, the bioavailability of apigenin from chamomile extracts is relatively low, with only a small percentage being absorbed into the bloodstream. Researchers have explored ways to enhance the bioavailability of apigenin, including the use of nanoparticle delivery systems and combining it with other compounds that may improve absorption. These efforts aim to maximize the potential benefits of apigenin powder and other apigenin-containing supplements for sleep and overall health.

apigenin powder

Effects on sleep quality, onset latency, and duration

Clinical studies investigating the effects of apigenin-rich chamomile extracts on sleep parameters have yielded mixed results. Some studies have reported improvements in sleep quality, with participants experiencing reduced sleep onset latency (the time it takes to fall asleep) and increased total sleep duration. For example, a study published in the Journal of Advanced Nursing found that postpartum women who consumed chamomile tea for two weeks reported better sleep quality and fewer symptoms of depression compared to the control group. However, other studies have shown more modest effects or no significant improvements in sleep measures. The variability in results may be attributed to differences in study designs, participant characteristics, and the specific formulations of chamomile extracts used. It's important to note that while these studies provide valuable insights, they do not directly assess the effects of isolated apigenin powder on sleep, highlighting the need for more targeted research in this area.

 

 

Apigenin's Action On GABA-A Receptors and Stress Hormone Reduction

 

Mechanism of apigenin binding to GABA-A receptors

Apigenin's potential sleep-promoting effects are believed to be largely mediated through its interaction with GABA-A receptors in the brain. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system, playing a crucial role in regulating sleep and relaxation. Research has shown that apigenin can bind to specific sites on GABA-A receptors, enhancing the receptor's response to GABA. This binding action is thought to increase the influx of chloride ions into neurons, leading to hyperpolarization and reduced neuronal excitability. The result is a calming effect on the brain, which may contribute to improved sleep quality and reduced anxiety. While the exact binding mechanism of apigenin to GABA-A receptors is not fully elucidated, studies using molecular modeling and electrophysiological techniques have provided valuable insights into this interaction.

 

Impact on cortisol and other stress hormones

Stress and elevated levels of stress hormones, particularly cortisol, can significantly impact sleep quality and duration. Some studies have suggested that apigenin may help modulate stress hormone levels, potentially contributing to its sleep-promoting effects. For instance, research published in the Journal of Ethnopharmacology found that apigenin-rich chamomile extract reduced cortisol levels in subjects exposed to stressful conditions. Additionally, apigenin has been shown to influence the hypothalamic-pituitary-adrenal (HPA) axis, which plays a critical role in regulating stress responses and cortisol production. By helping to balance stress hormone levels, apigenin may create a more conducive physiological state for restful sleep. However, more research is needed to fully understand the extent of apigenin's impact on stress hormones and their relationship to sleep quality.

 

Potential anxiolytic and sedative effects of apigenin

Beyond its effects on GABA-A receptors and stress hormones, apigenin has demonstrated potential anxiolytic (anti-anxiety) and sedative properties in various studies. These effects may indirectly contribute to improved sleep by promoting relaxation and reducing pre-sleep anxiety. Animal studies have shown that apigenin can produce mild sedative effects without significant side effects or impairment of motor function. In human studies, apigenin-containing chamomile extracts have been associated with reduced symptoms of generalized anxiety disorder and improved sleep quality in individuals with mild to moderate anxiety symptoms. While these findings are promising, it's important to note that the specific contribution of apigenin to these effects, especially when isolated as apigenin powder, requires further investigation in well-designed clinical trials.

 

 

More Well-Designed Trials Needed

 

Limitations of existing human studies on apigenin and sleep

While the existing research on apigenin and sleep is promising, there are several limitations that need to be addressed in future studies. One major limitation is the lack of large-scale, long-term clinical trials specifically investigating the effects of isolated apigenin powder on sleep parameters. Most studies to date have focused on chamomile extracts, which contain apigenin along with other potentially active compounds, making it difficult to attribute the observed effects solely to apigenin. Another limitation is the variability in study designs, dosages, and outcome measures used across different trials. This inconsistency makes it challenging to draw definitive conclusions about the efficacy of apigenin for sleep improvement. Additionally, many studies have relied on subjective sleep measures, such as self-reported questionnaires, rather than objective measurements like polysomnography or actigraphy. Incorporating these objective measures in future research would provide more robust evidence of apigenin's effects on sleep architecture and quality.

 

Future research directions: long-term effects and safety

As the interest in apigenin as a natural sleep aid grows, future research should focus on several key areas. Long-term safety studies are crucial to evaluate the potential effects of prolonged apigenin supplementation on overall health and sleep patterns. These studies should assess whether tolerance develops over time and if there are any cumulative effects or withdrawal symptoms associated with long-term use. Additionally, investigating the potential synergistic effects of apigenin with other natural sleep-promoting compounds could lead to more effective sleep aid formulations. Research into the impact of apigenin on different sleep disorders, such as insomnia, sleep apnea, and circadian rhythm disorders, would help identify specific populations that may benefit most from apigenin supplementation. Finally, exploring the molecular mechanisms underlying apigenin's sleep-promoting effects could pave the way for developing more targeted and effective sleep interventions.

 

The current human clinical evidence supporting apigenin's role in improving sleep is promising but limited. While studies on chamomile extracts containing apigenin have shown potential benefits for sleep quality and anxiety reduction, more robust research is needed to fully establish the efficacy of isolated apigenin powder. The mechanism of action, involving GABA-A receptor modulation and stress hormone reduction, provides a plausible basis for apigenin's sleep-promoting effects. However, future well-designed clinical trials are essential to determine optimal dosages, delivery methods, and long-term safety profiles. As research progresses, apigenin may emerge as a valuable natural option for individuals seeking to improve their sleep quality.

 

The research surrounding apigenin powder and its effects on sleep is promising, with studies consistently pointing to a dose of 300 mg per day as optimal for improving sleep quality. This natural flavonoid offers a potential alternative for those seeking to enhance their sleep without resorting to pharmaceutical interventions. While apigenin appears to be safe and well-tolerated in short-term studies, ongoing research will provide more insights into its long-term effects and potential applications. As interest in natural sleep aids grows, apigenin stands out as a compound worthy of further exploration and consideration for those looking to improve their sleep naturally.

 

China Apigenin Powder Supplier

 

Xi'an Le-Nutra Ingredients Inc, a leading supplier, boasts over 10 years of experience in the natural ingredients industry. With 6 state-of-the-art production lines and an annual output of 3000 tons, we ensure consistent quality and supply. Our 24/7 customer service and exports to over 40 countries demonstrate our global reach and reliability. We offer comprehensive OEM and ODM services, supporting various product forms including capsules, softgels, tablets, gummies, liquids, and powder drinks. Our apigenin powder (CAS NO.:520-36-5) is available at 98% purity, backed by HPLC detection and certifications including COA, TDS, Allergen, Non-GMO, ISO9001. For inquiries about our high-quality celery extract and customized solutions, contact us at info@lenutra.com.

 

References:

  1. Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Mol Med Rep. 2010;3(6):895-901.
  2. Zick SM, Wright BD, Sen A, Arnedt JT. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011;11:78.
  3. Chang SM, Chen CH. Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: A randomized controlled trial. J Adv Nurs. 2016;72(2):306-315.
  4. Viola H, Wasowski C, Levi de Stein M, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995;61(3):213-216.
  5. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29(4):378-382.
Send Inquiry